Sign in Subscribe

Archive

A collection of 715 issues

Latest

CRC Research Finding

Skip to content The CRC Digest ▪ Personalized ctDNA Test Detects Stage III Recurrence Before Imaging A case series of four stage III CRC patients showed the Signatera ctDNA assay detected recurrence earlier than imaging and informed curative interventions. (Cancer Diagnosis & Prognosis) This content is informational only and does not

CRC Research Update — July 01, 2026

Today's colorectal cancer research highlights

Prehabilitation study evaluates exercise and nutrition before GI cancer surgery

Skip to content The CRC Digest Prehabilitation study evaluates exercise and nutrition before GI cancer surgery A prospective controlled trial evaluates the feasibility, safety, and preliminary effectiveness of supervised moderate-to-high intensity exercise combined with nutritional counseling in gastrointestinal cancer patients scheduled for surgery. (BMC Cancer) This content is informational only

Cross-kingdom gut microbiome model predicts colorectal adenomas

Skip to content The CRC Digest Cross-kingdom gut microbiome model predicts colorectal adenomas Researchers analyzed 296 fecal samples using metagenomic sequencing and developed a predictive model incorporating bacteria, viruses, archaea, and fungi to identify colorectal adenomas, the main precancerous lesion. (Front Microbiol) This content is informational only and does not

French multicenter study to evaluate ctDNA after liver metastasis surgery

Skip to content The CRC Digest French multicenter study to evaluate ctDNA after liver metastasis surgery The CLIMES PRODIGE 77 study will enroll 232 patients undergoing curative-intent liver metastasis resection to evaluate circulating tumor DNA as a biomarker for detecting minimal residual disease and predicting prognosis. (BMJ Open) This content

Rare neurological syndrome as first sign of colon cancer in 43-year-old

Skip to content The CRC Digest Rare neurological syndrome as first sign of colon cancer in 43-year-old A 43-year-old man with progressive sensory neuropathy was diagnosed with Stage IIIA colon adenocarcinoma after anti-Hu antibodies led to discovery of an ascending colon mass; the patient had not undergone recommended early screening

CRC Research Finding

Skip to content The CRC Digest ▸ Multi-omics deep learning model predicts anti-EGFR therapy response in liver metastases A multi-center study developed a deep learning framework integrating multi-omics data to predict which RAS wild-type colorectal cancer liver metastases patients will benefit from cetuximab therapy, addressing primary resistance challenges. (Curr Cancer Drug

CRC Research Update — June 30, 2026

Today's colorectal cancer research highlights

CRC Research Finding

Skip to content The CRC Digest ◇ MMR Protein Expression Patterns Vary by Patient Characteristics A study of 80 Chinese CRC patients examined how deficient mismatch repair status relates to clinical features, providing insights into this key molecular subtype that affects immunotherapy response. (Front Med) This content is informational only and

CRC Research Update — June 29, 2026

Today's colorectal cancer research highlights